CM
ITCI

Capula Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Capula Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,800
Closed -$3.01M – 893
2025
Q1 		$3.01M Buy
+22,800
New +$2.84M 0.02% 164

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Capula Management's ITCI Position: Q2 2025 in Review

Capula Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 22,800 shares — an estimated $3.01M sold.

Capula Management first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $3.01M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Capula Management reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Capula Management sold 22,800 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $3.01M.
  • Capula Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • Capula Management's Intra-Cellular Therapies Inc. position peaked at $3.01M in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Capula Management's 13F filing for Q2 2025, filed 13 Aug 2025.